arrow
E

Emma Tham

karolinska institutet
H指数:32
被引数:3,512

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Surveillance adherence and clinical findings in children with confirmed or familial TP53 variants: the Swedish multicenter constitutional TP53 study (SWEP53)

对确诊或具有家族性TP53变异的儿童进行监测依从性及临床表现的调查:瑞典多中心先天性TP53研究(SWEP53)

2026-07-070
OA
The genomic medicine center Karolinska 10-year report on genome sequencing for rare diseases and a strategy for stepwise clinical implementation

卡罗林斯卡基因组医学中心关于罕见病基因组测序的10年报告及分步临床实施策略

2026-03-300
OAAI
Mesalamine for Colorectal Cancer Prevention Programme in Lynch syndrome (MesaCAPP): a multicentre, multinational, randomised, two-arm, double-blind, phase II clinical study with mesalamine or placebo in carriers with Lynch syndrome - a study protocol

美沙拉嗪用于林奇综合征结直肠癌预防计划(MesaCAPP):一项多中心、跨国、随机、双臂、双盲、II期临床研究,研究美沙拉嗪或安慰剂在林奇综合征携带者中的效果——研究方案

2025-11-090
OA
A Swedish genome-wide haplotype association analysis identifies novel candidate loci associated with endometrial cancer risk

一项瑞典全基因组单体型关联分析鉴定出与子宫内膜癌风险相关的新的候选位点。

2025-03-180
OA
Germline copy number variants and endometrial cancer risk

生殖细胞拷贝数变异与子宫内膜癌风险

2024-11-040
OAAI
TOWARDS CLINICAL IMPLEMENTATION OF LIQUID BIOPSY ANALYSIS FOR PAEDIATRIC BRAIN TUMOUR PATIENTS - A PAN-EUROPEAN EFFORT FOR STANDARDIZATION
2024-06-180
OAAI
Diagnostic yield and clinical impact of germline sequencing in children with CNS and extracranial solid tumors - a nationwide, prospective Swedish study
2024-04-012
OAAI
Extended genetic analysis and tumor characteristics in over 4600 women with suspected hereditary breast and ovarian cancer

超过4600名疑似遗传性乳腺癌和卵巢癌妇女的扩展遗传分析和肿瘤特征

2023-08-105
OAAI
Whole-genome informed circulating tumor DNA analysis by multiplex digital PCR for disease monitoring in B-cell lymphomas: a proof-of-concept study
2023-06-024
OAAI
Genome sequencing is a sensitive first-line test to diagnose individuals with intellectual disability

基因组测序是诊断智障人士的敏感的一线测试

2022-11-0117
OA